Metabolic and functional effects of low-potassium cardioplegic solutions for long-term heart preservation

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 8, Issue 2, 1999, Pages 77-82

  Desrois, M ^a   Sciaky, M ^a   Lan, C ^a   Cozzone, P J ^a   Bernard, M ^a  

^a CNRS   (France)

Author keywords

Heart; Ischemia reperfusion; MRS; Potassium; Preservation

Indexed keywords

CARDIOPLEGIC AGENT; POTASSIUM;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL FUNCTION; CELL PH; ENDOTHELIUM; HEART PERFUSION; HEART PRESERVATION; HIGH ENERGY PHOSPHATE; ISOLATED HEART; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; CARDIOPLEGIC SOLUTIONS; CREATINE KINASE; ENERGY METABOLISM; HEART ARREST, INDUCED; HEART RATE; L-LACTATE DEHYDROGENASE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL ISCHEMIA; ORGAN PRESERVATION; POTASSIUM; PURINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 0032798638     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1352-8661(99)00016-2     Document Type: Article

References (22)

1. Rich T.L., Brady A.J. Potassium contracture and utilization of high-energy phosphates in rabbit heart. Am J Physiol. 226:1974;105-113.
2. Olinger G.N., Boerboom L.E., Bonchek L.I., Hutchinson L.D., Kissebah A.H. Hyperkalemia in cardioplegic solutions causing increased cholesterol accumulation in vein grafts. J Thorac Cardiovasc Surg. 85:1983;590-594.
3. Saldanha C., Hearse D.J. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. J Thorac Cardiovasc Surg. 98:1989;783-787.
4. Chan B.B.K., Kron I.L., Flanagan T.L., Kern J.A., Hobson C.E., Tribble C.G. Impairment of vascular endothelial function by high-potassium storage solutions. Ann Thorac Surg. 55:1993;940-945.
5. Mankad P.S., Chester A.H., Yacoub M.H. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg. 51:1991;89-93.
6. Bernard M., Caus T., Sciaky M., Monties J.R., Cozzone P.J. Assessment of a new cardioplegic solution for long-term heart preservation: experimental study using 31-P magnetic resonance spectroscopy and biochemical analyses. Transplant Proc. 28:1996;48-49.
7. 31P nuclear magnetic resonance analysis of metabolite concentrations in Langendorff-perfused rabbit hearts. Biophys J. 48:1985;803-813.
8. Karck M., Vivi A., Tassini M., Schwalb H., Askenasy N., Navon G., Borman J.B., Uretzky G. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery. J Thorac Cardiovasc Surg. 104:1992;1356-1364.
9. Kost G.J. pH standardization for phosphorus-31 magnetic resonance heart spectroscopy at different temperatures. Magn Reson Med. 14:1990;496-506.
10. 31P magnetic resonance spectroscopy. Circulation. 90(part 2):1994;II328-II338.
11. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 69:1967;696-705.
12. Ames B.N. Assay of inorganic phosphates, total phosphate and phosphatases. Methods Enzymol. 8:1966;115-118.
13. Gutman I., Wahlefeld A.W. L-(+)-lactate determination with lactate dehydrogenase and NAD. Bergmeyer H.U. Methods of enzymatic analysis. 1974;266-270 Academic Press, New York.
14. Wynants J., Petrov B., Nijhof J., Van Belle H. Optimization of a HPLC method for the determination of nucleosides and their catabolites. Application to cat and rabbit heart perfusates. J Chromatogr. 386:1987;297-308.
15. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
16. Bernstein L.K., Everse J. Determination of the isoenzyme levels of lactate dehydrogenase. Methods Enzymol. 41:1975;47-52.
17. Portmann M.A., Eyster G.E. Myocardial buffering capacity and high-energy phosphates utilization during hypothermic circulatory arrest and recovery in the newborn lamb in vivo. J Thorac Cardiovasc Surg. 108:1994;946-952.
18. Hearse D.J., Stewart D.A., Braimbridge M.V. Hypothermic arrest and potassium arrest. Metabolic and myocardial protection during elective cardiac arrest. Circ Res. 36:1975;481-489.
19. Mankad P.S., Chester A.H., Yacoub M.H. Ischaemic endothelial dysfunction after single or multidose cardioplegia. Eur Heart J. 13:1992;976-980.
20. Mankad P., Slavik Z., Yacoub M. Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart. J Thorac Cardiovasc Surg. 104:1992;1618-1624.
21. Lochner W., Arnold G., Muller-Ruchholtz E.R. Metabolism of the artificially arrested heart and of the gas perfused heart. Am J Cardiol. 22:1968;299-311.
22. Sobel B.E., Shell W.E. Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation. XLV:1972;471-482.